Cargando…

Synergistic effect of gefitinib and rofecoxib in mesothelioma cells

BACKGROUND: Malignant mesothelioma (MM) is an aggressive tumor that is resistant to conventional modes of treatment with chemotherapy, surgery or radiation. Research into the molecular pathways involved in the development of MM should yield information that will guide therapeutic decisions. Epiderma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stoppoloni, Daniela, Canino, Claudia, Cardillo, Irene, Verdina, Alessandra, Baldi, Alfonso, Sacchi, Ada, Galati, Rossella
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828989/ https://www.ncbi.nlm.nih.gov/pubmed/20122271 http://dx.doi.org/10.1186/1476-4598-9-27

Ejemplares similares

Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability
por: Verdina, Alessandra, et al.
Publicado: (2008)

Retraction Note: Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability
por: Verdina, Alessandra, et al.
Publicado: (2022)

Selective inhibition of prostacyclin synthase activity by rofecoxib
por: Griffoni, Cristiana, et al.
Publicado: (2007)

A comparison of the effects of ibuprofen and rofecoxib on rabbit fibula osteotomy healing
por: O'Connor, J Patrick, et al.
Publicado: (2009)

Rofecoxib for dysmenorrhoea: meta-analysis using individual patient data
por: Edwards, Jayne E, et al.
Publicado: (2004)

Individual patient meta-analysis of single-dose rofecoxib in postoperative pain
por: Edwards, Jayne E, et al.
Publicado: (2004)

Hidden Cardiotoxicity of Rofecoxib Can be Revealed in Experimental Models of Ischemia/Reperfusion
por: Brenner, Gábor B., et al.
Publicado: (2020)

Identification of New Rofecoxib-Based Cyclooxygenase-2 Inhibitors: A Bioinformatics Approach
por: Leão, Rozires P., et al.
Publicado: (2020)

Development and validation of an HPLC method for determination of rofecoxib in bovine serum albumin microspheres
por: DEMİRTÜRK, Esra, et al.
Publicado: (2020)

Risk/benefit trade-offs in rheumatology: rofecoxib revisited in the era of JAK inhibitors
por: Hazlewood, Glen S
Publicado: (2023)

A Study on Improvement of Solubility of Rofecoxib and its effect on Permeation of Drug from Topical Formulations
por: Kulkarni, Madhur, et al.
Publicado: (2008)

Reactive oxygen species a double-edged sword for mesothelioma
por: Benedetti, Serena, et al.
Publicado: (2015)

Single-dose rofecoxib for acute postoperative pain in adults: a quantitative systematic review
por: Barden, Jodie, et al.
Publicado: (2002)

Rofecoxib Attenuates the Pathogenesis of Amyotrophic Lateral Sclerosis by Alleviating Cyclooxygenase-2-Mediated Mechanisms
por: Zou, Yan-Hui, et al.
Publicado: (2020)

Carboranyl Derivatives of Rofecoxib with Cytostatic Activity against Human Melanoma and Colon Cancer Cells
por: Buzharevski, Antonio, et al.
Publicado: (2020)

The Tell-Tale Heart: Population-Based Surveillance Reveals an Association of Rofecoxib and Celecoxib with Myocardial Infarction
por: Brownstein, John S., et al.
Publicado: (2007)

Synergistic induction of apoptosis by salinomycin and gefitinib through lysosomal and mitochondrial dependent pathway overcomes gefitinib resistance in colorectal cancer
por: Zou, Zheng-Zhi, et al.
Publicado: (2015)

Gefitinib or lapatinib with foretinib synergistically induce a cytotoxic effect in melanoma cell lines
por: Dratkiewicz, Ewelina, et al.
Publicado: (2018)

Arachidonic acid drives adaptive responses to chemotherapy-induced stress in malignant mesothelioma
por: Cioce, Mario, et al.
Publicado: (2021)

Short-Term Efficacy of Rofecoxib and Diclofenac in Acute Shoulder Pain: A Placebo-Controlled Randomized Trial
por: Dougados, Maxime, et al.
Publicado: (2007)

Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine
por: Krymchantowski, Abouch Valenty, et al.
Publicado: (2004)

Comparación del rofecoxib versus paracetamol en el tratamiento del dolor en la gonartrosis
por: Santiago Ortiz, Ramón
Publicado: (2004)

Lack of Small Intestinal Dysbiosis Following Long-Term Selective Inhibition of Cyclooxygenase-2 by Rofecoxib in the Rat
por: Lázár, Bernadette, et al.
Publicado: (2019)

Apoptosis Induced by Piroxicam plus Cisplatin Combined Treatment Is Triggered by p21 in Mesothelioma
por: Baldi, Alfonso, et al.
Publicado: (2011)

Piroxicam and intracavitary platinum-based chemotherapy for the treatment of advanced mesothelioma in pets: preliminary observations
por: Spugnini, Enrico P, et al.
Publicado: (2008)

Efatutazone and T0901317 exert synergistically therapeutic effects in acquired gefitinib‐resistant lung adenocarcinoma cells
por: Ni, Jie, et al.
Publicado: (2018)

Rofecoxib prevents ctdsDNA against damage induced by copper sulfate and ultraviolet B radiation in vitro study
por: Al-Nimer, Marwan S. M., et al.
Publicado: (2010)

Correction: Short-Term Efficacy of Rofecoxib and Diclofenac in Acute Shoulder Pain: A Placebo-Controlled Randomized Trial
Publicado: (2007)

Curcumin as an Anticancer Agent in Malignant Mesothelioma: A Review
por: Baldi, Alfonso, et al.
Publicado: (2020)

COX-2 Inhibition by Use of Rofecoxib or High Dose Aspirin Enhances ADP-Induced Platelet Aggregation in Fresh Blood
por: Borgdorff, Piet, et al.
Publicado: (2010)

Incidence of spontaneous notifications of adverse reactions with aceclofenac, meloxicam, and rofecoxib during the first year after marketing in the United Kingdom
por: Raber, Anna, et al.
Publicado: (2007)

Renal function during rofecoxib therapy in patients with metastatic cancer: retrospective analysis of a prospective phase II trial
por: Reinhold, Stephan W, et al.
Publicado: (2011)

Synergistic Antitumor Effect between Gefitinib and Fractionated Irradiation in Anaplastic Oligodendrogliomas Cannot Be Predicted by the Egfr Signaling Activity
por: Pinel, Sophie, et al.
Publicado: (2013)

Synergistic Effect of Afatinib with Su11274 in Non-Small Cell Lung Cancer Cells Resistant to Gefitinib or Erlotinib
por: Chen, Gang, et al.
Publicado: (2013)

Synergistic Effect of HAD-B1 and Afatinib Against Gefitinib Resistance of Non-Small Cell Lung Cancer
por: Song, Si Yeon, et al.
Publicado: (2022)

Structural Examination of 6-Methylsulphonylphenanthro-[9,10-C]-furan-1(3H)-one—A Rofecoxib Degradation Product
por: Dean, Pamela M.
Publicado: (2010)

Reduction of estradiol in human malignant pleural mesothelioma tissues may prevent tumour growth, as implied by in in-vivo and in-vitro models
por: Nuvoli, Barbara, et al.
Publicado: (2016)

Autocrine CSF-1R signaling drives mesothelioma chemoresistance via AKT activation
por: Cioce, M, et al.
Publicado: (2014)

Pilot study of radiofrequency hyperthermia in combination with gefitinib in gefitinib‐effective patients with advanced NSCLC
por: Qin, Yijia, et al.
Publicado: (2016)

Estrogen Receptor β Exerts Tumor Repressive Functions in Human Malignant Pleural Mesothelioma via EGFR Inactivation and Affects Response to Gefitinib
por: Pinton, Giulia, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_00m9bbqg0ct15i5hnb9rt4812o